We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

181 hedge funds and large institutions have $1.11B invested in Arcus Biosciences in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more call options, than puts

Call options by funds: $26.7M | Put options by funds: $23.2M

13% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 23

10% more capital invested

Capital invested by funds: $1.01B → $1.11B (+$98.2M)

1% more funds holding

Funds holding: 179 → 181 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 65

1.11% less ownership

Funds ownership: 75.93% → 74.82% (-1.1%)

Holders
181
Holders Change
+2
Holders Change %
+1.12%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
26
Increased
59
Reduced
65
Closed
23
Calls
$26.7M
Puts
$23.2M
Net Calls
+$3.5M
Net Calls Change
+$742K

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$35.5M
2
Ameriprise
Ameriprise
Minnesota
+$24.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
4
LGM
Logos Global Management
California
+$14.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.5M

Top Sellers

1
State Street
State Street
Massachusetts
-$22M
2
Citadel Advisors
Citadel Advisors
Florida
-$19.6M
3
Bank of America
Bank of America
North Carolina
-$18.3M
4
BlackRock
BlackRock
New York
-$12.7M
5
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
DI
176
Disciplined Investments
Oklahoma
$81 +$38 +2 +100%
AF
177
Advisornet Financial
Minnesota
$61 -$19 -1 -25%
Northwestern Mutual Wealth Management
178
Northwestern Mutual Wealth Management
Wisconsin
$20 – – –
Verition Fund Management
179
Verition Fund Management
Connecticut
– -$6.53M -357,986 Closed
AQR Capital Management
180
AQR Capital Management
Connecticut
– -$4.04M -221,257 Closed
TCM
181
Tang Capital Management
California
– -$2.7M -147,920 Closed
PP
182
PDT Partners
New York
– -$947K -51,925 Closed
TC
183
Tejara Capital
United Kingdom
– -$912K -50,000 Closed
1CM
184
1492 Capital Management
Wisconsin
– -$561K -30,733 Closed
VIA
185
Vident Investment Advisory
Georgia
– -$425K -23,276 Closed
SO
186
STRS Ohio
Ohio
– -$412K -22,600 Closed
GCP
187
GSA Capital Partners
United Kingdom
– -$381K -20,886 Closed
TI
188
Trexquant Investment
Connecticut
– -$343K -18,827 Closed
NC
189
NinePointTwo Capital
California
– -$290K -15,916 Closed
First Trust Advisors
190
First Trust Advisors
Illinois
– -$289K -15,845 Closed
WVP
191
Worth Venture Partners
New Jersey
– -$242K -12,700 Closed
SG Americas Securities
192
SG Americas Securities
New York
– -$222K -12,184 Closed
HW
193
Hancock Whitney
Mississippi
– -$218K -11,945 Closed
SFI
194
Susquehanna Fundamental Investments
Pennsylvania
– -$204K -11,180 Closed
CM
195
Caption Management
Oklahoma
– -$171K -9,000 Closed
SOW
196
State of Wyoming
Wyoming
– -$56.6K -3,104 Closed
Royal Bank of Canada
197
Royal Bank of Canada
Ontario, Canada
– -$56.5K -2,969 -99%
Acadian Asset Management
198
Acadian Asset Management
Massachusetts
– -$26K -1,444 Closed
BWL
199
Bogart Wealth LLC
Virginia
– -$474 -26 Closed
SC
200
Schubert & Co
Texas
– -$201 -11 Closed
5 6 7
8
9

RCUS Hedge Fund Activity: Q2 2023 in Review

181 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2023, worth a combined $1.11B — up 9.7% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCUS positions and 23 closed out — a net gain of 3 holders — while 59 added to existing stakes and 65 trimmed.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $35.5M. The largest seller was State Street, cutting an estimated $22M.

  • 181 institutional investors held Arcus Biosciences (RCUS) as of Q2 2023, up from 179 in Q1 2023.
  • Funds reported $1.11B of Arcus Biosciences stock for Q2 2023, up 9.7% quarter-over-quarter.
  • 26 funds opened new Arcus Biosciences positions in Q2 2023 and 23 closed out, a net change of +3 holders.
  • The largest Arcus Biosciences buyer in Q2 2023 was Balyasny Asset Management, an estimated $35.5M added.
  • The largest Arcus Biosciences seller in Q2 2023 was State Street, an estimated $22M sold.

Based on aggregated 13F filings for Q2 2023.